NSEStatement of deviation(s) or variation(s) under Reg. 326d ago · 2 Nov 2026, 05:09 pm
Statement of deviation(s) or variation(s) under Reg. 32
Cineline India Limited · CINELINE
✦ AI SummaryResults
Cineline India Limited has informed the Exchange about a statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended September 30, 2026, stating that there is no deviation(s) or variation(s) in the utilization of proceeds raised through allotment of convertible warrants.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cineline India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Attachments (1)
📄pdf
Download →
CINELINE_02112026170835_Statement_of_Deviation.pdf
View document text
Date: 2nd November 2026
To, To,
BSE Limited, National Stock Exchange of India Limited
Department of Corporate Services, Listing Department,
Phiroze Jeejeebhoy Towers, Exchange Plaza, C- 1, Block G, Bandra Kurla
Dalal Street, Mumbai – 400001 Complex, Bandra (East), Mumbai– 400051
Scrip Code: 532807 Scrip Code: CINELINE
Sub: Statement of deviation(s) or variation(s) for the quarter ended September 30, 2026 under
regulation 32(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”)
Dear Sir/Ma’am,
Pursuant to Regulation 32 of the SEBI Listing Regulations read with SEBI Circular No.
CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there is no
deviation(s) or variation(s) in the utilization of proceeds raised through allotment of 38,46,153
Equity Shares of face value of ₹5/- each upon conversion/ exchange of/ for equal number of
Warrants at an issue price of ₹117 each upon receipt of balance amount at the rate of ₹87.75 per
warrant (being 75% of the issue price per warrant as “Warrant Exercise Price”) aggregating to
₹33,74,99,925.75/-
A NIL statement of deviation(s) or variation(s), for the aforesaid period, in respect of utilization
of proceeds for the Quarter ended September 30, 2026, is duly reviewed by the Audit Committee
of the Company and the same is enclosed with this letter.
Kindly take the same on your records.
For Cineline India Limited
Mr. Rasesh Kanakia
Chairman & Whole Time Director
DIN:00015857
Encl.: As Above
Cineline India Limited
2nd Floor, A & B wing, Vilco Centre, Subhash Road, Opp Garware, Vile Parle (E), Mumbai- 400057 (India)
Tel: 91-22-67266688, email: investor@cineline.co.in, Corporate Identity Number (CIN): L92142MH2002PLC135964, www.moviemax.co.in
Statement of deviation/ variation in utilization of funds raised:
Particulars Details
Name of listed entity Cineline India Limited
Mode of fund raising Preferential Issue of Convertible Warrants
Amount raised (Rs. in Crore) 4499.99 Lakhs
Report filed for quarter ended 30th September, 2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable Not Applicable
Is there a deviation/ variation in use of No
funds raised
If Yes, whether the same is pursuant to Not Applicable
change in terms of contracts or objects
which was approved by the
shareholders
If yes, date of shareholders’ Approval Not Applicable
Explanation for the deviation/ variation Not Applicable
Comments of the audit committee Nil
after review
Comments of the auditors, if any Nil
Objects for which funds have been raised and where there has been a deviation/ variation, in
the following table: Not Applicable
Original Modified Original Modified Funds Amount of Remarks,
object object, allocation allocation, Utilized deviation/ if any
if any if any variation
for the
quarter
according
applicable
object (in
Rs. crore
and in %)
Issue NA 4499.99 NA 3832.96 0 -
proceeds Lakhs Lakhs
shall be
utilized to
meet the
funding
requirements
for the
Cineline India Limited
2nd Floor, A & B wing, Vilco Centre, Subhash Road, Opp Garware, Vile Parle (E), Mumbai- 400057 (India)
Tel: 91-22-67266688, email: investor@cineline.co.in, Corporate Identity Number (CIN): L92142MH2002PLC135964, www.moviemax.co.in
growth in the
business of
Company,
general
corporate
purposes and
the working
capital
requirements
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter
of offer, etc.
Thanks & Regards,
For Cineline India Limited
Mr. Rasesh Kanakia
Chairman & Whole Time Director
DIN:00015857
Cineline India Limited
2nd Floor, A & B wing, Vilco Centre, Subhash Road, Opp Garware, Vile Parle (E), Mumbai- 400057 (India)
Tel: 91-22-67266688, email: investor@cineline.co.in, Corporate Identity Number (CIN): L92142MH2002PLC135964, www.moviemax.co.in